Carrie Brownstein

Insider Reports History

Entity
Individual
Location
500 W. 5 Th St., Suite 1200, Austin, TX
Signature
/s/ Andrew R. Neill, Attorney-in-Fact for Carrie Brownstein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carrie Brownstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Medical Officer Common Stock 106K $1.09M $10.29 Oct 4, 2023 Direct
Shattuck Labs, Inc. Director Stock Option (Right to Buy) 27.7K Jun 21, 2024 Direct

Insider Reports Filed by Carrie Brownstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STTK Shattuck Labs, Inc. Jun 21, 2024 1 $0 4 Jun 21, 2024 Director
ZNTL Zentalis Pharmaceuticals, Inc. Oct 4, 2023 2 -$207K 4 Oct 6, 2023 Chief Medical Officer
STTK Shattuck Labs, Inc. May 26, 2023 1 $0 4 May 31, 2023 Director
ZNTL Zentalis Pharmaceuticals, Inc. Feb 1, 2023 2 $0 4 Feb 1, 2023 Chief Medical Officer
ZNTL Zentalis Pharmaceuticals, Inc. Oct 3, 2022 3 $0 4 Oct 3, 2022 Chief Medical Officer
ZNTL Zentalis Pharmaceuticals, Inc. Oct 3, 2022 0 $0 3 Oct 3, 2022 Chief Medical Officer
STTK Shattuck Labs, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
STTK Shattuck Labs, Inc. Nov 12, 2021 1 $0 4 Nov 17, 2021 Director
STTK Shattuck Labs, Inc. Oct 22, 2021 0 $0 3 Nov 17, 2021 Director